Bardelli, Alberto - Search Results - UAB Digital Repository of Documents

Search collections:

Sort by:	Display results:	Output format:

UAB Digital Repository of Documents	2 records found	Search took 0.00 seconds.

8 p, 500.4 KB

Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer / Siena, S. (Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy) ; Sartore-Bianchi, A. (Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy) ; García-Carbonero, Rocío (Universidad Complutense de Madrid) ; Karthaus, M. (Department for Hematology and Oncology, Staedt Klinikum Neuperlach and Harlaching, Munich, Germany) ; Smith, D. (Bordeaux University Hospital (França)) ; Tabernero, Josep (Universitat Autònoma de Barcelona) ; Van Cutsem, E. (KU Leuven, Leuven, Belgium) ; Guan, X (Amgen Inc., Thousand Oaks, CA, USA) ; Boedigheimer, M. (Amgen Inc., Thousand Oaks, CA, USA) ; Ang, A. (Amgen Inc., Thousand Oaks, CA, USA) ; Twomey, B. (Amgen Inc., Thousand Oaks, CA, USA) ; Bach, B. A. (Amgen Inc., Thousand Oaks, CA, USA) ; Jung, A. S. (Amgen Inc., Thousand Oaks, CA, USA) ; Bardelli, Alberto (Department of Oncology, University of Torino, Candiolo, Italy)
Mutations in rat sarcoma (RAS) genes may be a mechanism of secondary resistance in epidermal growth factor receptor inhibitor-treated patients. Tumor-tissue biopsy testing has been the standard for evaluating mutational status; however, plasma testing of cell-free DNA has been shown to be a more sensitive method for detecting clonal evolution. [...]
2017 - DOI (Digital Object Identifier)

10.1093/annonc/mdx504
Annals of oncology, Vol. 29 (september 2017) , p. 119-126

Detailed record -

27 p, 8.4 MB

Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model / Álamo, Patricia (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Gallardo, Alberto (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Di Nicolantonio, Federica (Università degli studi di Torino. Dipartimento di Oncologia) ; Pavón Ribas, Miguel Ángel (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Casanova Rigat, Isolda (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Trias Folch, Manuel (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Mangues, Ma Antonia (Institut d'Investigació Biomèdica Sant Pau) ; López Pousa, Antonio (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Villaverde Corrales, Antonio (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Vázquez Gómez, Esther (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Bardelli, Alberto (Università degli studi di Torino. Dipartimento di Oncologia) ; Céspedes, María Virtudes (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Mangues, Ramon 1957- (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina)
Although all KRas (protein that in humans is encoded by the KRas gene) point mutants are considered to have a similar prognostic capacity, their transformation and tumorigenic capacities vary widely. [...]
2015 - DOI (Digital Object Identifier)

10.1096/fj.14-262303
The FASEB journal, Vol. 29 Issue 2 (Feb. 2015) , p. 464-476

Detailed record -

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.